Fingerprint
Dive into the research topics where Kyoung Eun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
Korean Cancer Study Group (KCSG) Breast Cancer Committee, Oct 2025, In: ESMO Open. 10, 10, 105804.Research output: Contribution to journal › Article › peer-review
Open Access -
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)
Lee, J., Lee, D. W., Kim, M. H., Kim, J. H., Kim, J. W., Byun, J. H., Lee, K. E., Kang, M. J., Koh, S. J., Hong, S., Won, H. S., Kim, H. J., Park, I. H., Shin, S. H., Baek, S. K., Kim, S. G., Koh, S. A., Jung, J. Y., Kim, J. Y. & Kim, G. M. & 5 others, , Aug 2025, In: Breast. 82, 104500.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Prevalence of germline BRCA1/2 pathogenic variants in unselected Korean patients with HER2-negative metastatic breast cancer: a nationwide prospective study (KCSG BR19-10)
Ahn, H. K., Kim, J. H., Koh, S. J., Sohn, J., Kang, M. J., Jung, K. H., Lee, K. E., Lee, J., Koh, S. A., Chae, Y. S., Byun, J. H., Park, I. H., Kim, H. J., Kim, J. H., Kim, H. J., Jung, J. Y., Lee, J. L., Cho, Y. Y., Park, K. H. & Kim, J. Y. & 2 others, , Jul 2025, In: The Lancet Regional Health - Western Pacific. 60, 101622.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer
Jeon, S. H., Suh, K. J., Jung, S., Jeon, M., Jang, H. C., Kim, E. S., Kim, S. H., Lee, K. H., Im, S. A., Kim, M. H., Sohn, J., Jeong, J. H., Jung, K. H., Lee, K. E., Park, Y. H., Kim, H. J., Cho, E. K., Choi, I. S., Park, S. Y. & Kim, M. & 2 others, , 1 Nov 2025, In: Clinical Cancer Research. 31, 21, p. 4586-4597 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
Korean Cancer Study Group (KCSG) Breast Cancer Committee, Dec 2025, In: BMC Cancer. 25, 1, 1295.Research output: Contribution to journal › Article › peer-review
Open Access